Alembic Limited (ALEMBICLTD.BO)
- Previous Close
110.09 - Open
109.10 - Bid 111.03 x --
- Ask 111.61 x --
- Day's Range
109.10 - 112.00 - 52 Week Range
85.55 - 169.00 - Volume
49,410 - Avg. Volume
51,257 - Market Cap (intraday)
28.531B - Beta (5Y Monthly) 0.68
- PE Ratio (TTM)
9.18 - EPS (TTM)
12.10 - Earnings Date Aug 11, 2025 - Aug 15, 2025
- Forward Dividend & Yield 2.40 (2.16%)
- Ex-Dividend Date Aug 5, 2024
- 1y Target Est
--
Alembic Limited engages in real estate business in India and internationally. It operates through Active Pharmaceutical Ingredient (API) and Real Estate segments. The company constructs residential and commercial real estate projects; provision of project management and marketing consultancy services; and leasing of commercial properties. It manufactures and markets fermentation and chemistry based on active pharmaceutical ingredient; and engages in research and development. In addition, it is involved in power generation through co-generation plants and wind power sources. The company serves individuals, corporates, business houses, and pharmaceutical companies. The company was founded in 1907 and is based in Vadodara, India. Alembic Limited is a subsidiary of Nirayu Pvt. Ltd.
www.alembiclimited.com--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: ALEMBICLTD.BO
View MorePerformance Overview: ALEMBICLTD.BO
Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALEMBICLTD.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALEMBICLTD.BO
View MoreValuation Measures
Market Cap
28.53B
Enterprise Value
28.05B
Trailing P/E
9.18
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
12.86
Price/Book (mrq)
1.22
Enterprise Value/Revenue
12.64
Enterprise Value/EBITDA
16.64
Financial Highlights
Profitability and Income Statement
Profit Margin
140.01%
Return on Assets (ttm)
2.15%
Return on Equity (ttm)
13.73%
Revenue (ttm)
2.22B
Net Income Avi to Common (ttm)
3.11B
Diluted EPS (ttm)
12.10
Balance Sheet and Cash Flow
Total Cash (mrq)
594.7M
Total Debt/Equity (mrq)
0.62%
Levered Free Cash Flow (ttm)
75.16M